New Ulcerative Colitis Drug Shows Promise with Targeted Delivery and Strong Anti-Inflammatory Effects
A new experimental drug called PALI-2108, developed by Palisade Bio, has shown promising results in early-stage clinical trials for treating […]
Pharmaceutical News
UK Company Creates Lab-Grown Human Muscle to Speed Up Drug Development and Reduce Animal Testing
A biotechnology company in the UK has introduced a groundbreaking new method for testing new medicines using lab-grown human muscle.
Pharmaceutical News
New Wegovy Pill for Weight Loss Shows Strong Early Success in U.S.
A new weight-loss medication called Wegovy, which comes as an easy-to-take pill instead of an injection, has been prescribed over
Pharmaceutical News
FDA Launches Short, Focused Inspections to Improve Drug Safety Monitoring
The U.S. Food and Drug Administration (FDA) is testing a new way to inspect drug manufacturing facilities to make sure
Pharmaceutical News
Why the Future of Medicine Depends on Better Measurement Tools – A Pharmacist Explains
Biomanufacturing is moving toward smarter, faster, and more automated ways to produce medicines, but there’s a big problem: the technology
New FDA-Approved Depression Medication Available in the U.S.
Axsome Therapeutics has just received official approval from the U.S. Food and Drug Administration (FDA) for a new medication called
Pharmaceutical News
New Hope for Blindness: How Cell Therapy Could Restore Vision
Vision loss from retinal diseases is a growing problem worldwide, making it harder for people to live independently and enjoy
Pharmaceutical News
New Research Helps Safely Develop Affordable Generic Osteoporosis Treatments
A recent study by EpiVax and Cubrc, in partnership with the U.S. Food and Drug Administration (FDA), has made it
Pharmaceutical News
New Hope for Future Medicines from Bristol Myers Squibb: What You Should Know
Bristol Myers Squibb (BMS), a major pharmaceutical company based in New Jersey, is generating excitement among investors with news about
Pharmaceutical News
Eli Lilly Reports Strong Sales Growth for Diabetes and Obesity Drugs, Raising Annual Revenue Outlook
Eli Lilly, a leading pharmaceutical company, has reported impressive financial results for the first three months of 2026, driven largely